212 related articles for article (PubMed ID: 16708053)
1. Intracisternal A-particle element in the 3' noncoding region of the mu-opioid receptor gene in CXBK mice: a new genetic mechanism underlying differences in opioid sensitivity.
Han W; Kasai S; Hata H; Takahashi T; Takamatsu Y; Yamamoto H; Uhl GR; Sora I; Ikeda K
Pharmacogenet Genomics; 2006 Jun; 16(6):451-60. PubMed ID: 16708053
[TBL] [Abstract][Full Text] [Related]
2. Characterization of the 3' untranslated region of the human mu-opioid receptor (MOR-1) mRNA.
Ide S; Han W; Kasai S; Hata H; Sora I; Ikeda K
Gene; 2005 Dec; 364():139-45. PubMed ID: 16122888
[TBL] [Abstract][Full Text] [Related]
3. Differential expression of mu-opioid receptor gene in CXBK and B6 mice by Sp1.
Lee PW; Wu S; Lee YM
Mol Pharmacol; 2004 Dec; 66(6):1580-4. PubMed ID: 15562256
[TBL] [Abstract][Full Text] [Related]
4. Association of morphine-induced antinociception with variations in the 5' flanking and 3' untranslated regions of the mu opioid receptor gene in 10 inbred mouse strains.
Shigeta Y; Kasai S; Han W; Hata H; Nishi A; Takamatsu Y; Hagino Y; Yamamoto H; Koide T; Shiroishi T; Kasai K; Tsunashima K; Kato N; Ikeda K
Pharmacogenet Genomics; 2008 Nov; 18(11):927-36. PubMed ID: 18854775
[TBL] [Abstract][Full Text] [Related]
5. The untranslated region of (mu)-opioid receptor mRNA contributes to reduced opioid sensitivity in CXBK mice.
Ikeda K; Kobayashi T; Ichikawa T; Kumanishi T; Niki H; Yano R
J Neurosci; 2001 Feb; 21(4):1334-9. PubMed ID: 11160404
[TBL] [Abstract][Full Text] [Related]
6. A major species of mouse mu-opioid receptor mRNA and its promoter-dependent functional polyadenylation signal.
Wu Q; Hwang CK; Yao S; Law PY; Loh HH; Wei LN
Mol Pharmacol; 2005 Aug; 68(2):279-85. PubMed ID: 15879516
[TBL] [Abstract][Full Text] [Related]
7. Identification of three mouse mu-opioid receptor (MOR) gene (Oprm1) splice variants containing a newly identified alternatively spliced exon.
Doyle GA; Rebecca Sheng X; Lin SS; Press DM; Grice DE; Buono RJ; Ferraro TN; Berrettini WH
Gene; 2007 Feb; 388(1-2):135-47. PubMed ID: 17156941
[TBL] [Abstract][Full Text] [Related]
8. In vivo regulation of mu-opioid receptor density and gene expression in CXBK and outbred Swiss Webster mice.
Duttaroy A; Yoburn BC
Synapse; 2000 Aug; 37(2):118-24. PubMed ID: 10881033
[TBL] [Abstract][Full Text] [Related]
9. Identification and functional significance of polymorphisms in the mu-opioid receptor gene (Oprm) promoter of C57BL/6 and DBA/2 mice.
Doyle GA; Sheng XR; Schwebel CL; Ferraro TN; Berrettini WH; Buono RJ
Neurosci Res; 2006 Jul; 55(3):244-54. PubMed ID: 16644048
[TBL] [Abstract][Full Text] [Related]
10. Reduced supraspinal nociceptive responses and distinct gene expression profile in CXBH recombinant inbred mice.
Kasai S; Ikeda K
J Pain; 2013 Jun; 14(6):648-61. PubMed ID: 23583704
[TBL] [Abstract][Full Text] [Related]
11. A possible genetic mechanism underlying individual and interstrain differences in opioid actions: focus on the mu opioid receptor gene.
Han W; Ide S; Sora I; Yamamoto H; Ikeda K
Ann N Y Acad Sci; 2004 Oct; 1025():370-5. PubMed ID: 15542738
[TBL] [Abstract][Full Text] [Related]
12. Identification of five mouse mu-opioid receptor (MOR) gene (Oprm1) splice variants containing a newly identified alternatively spliced exon.
Doyle GA; Sheng XR; Lin SS; Press DM; Grice DE; Buono RJ; Ferraro TN; Berrettini WH
Gene; 2007 Jun; 395(1-2):98-107. PubMed ID: 17398041
[TBL] [Abstract][Full Text] [Related]
13. Ethanol drinking-in-the-dark facilitates behavioral sensitization to ethanol in C57BL/6J, BALB/cByJ, but not in mu-opioid receptor deficient CXBK mice.
Tarragón E; Baliño P; Aragon CM; Pastor R
Pharmacol Biochem Behav; 2012 Mar; 101(1):14-23. PubMed ID: 22138236
[TBL] [Abstract][Full Text] [Related]
14. Analgesic effect of mu- and kappa-opioid agonists in beige and CXBK mice.
Muraki T; Oike N; Shibata Y; Nomoto T
J Pharm Pharmacol; 1991 Mar; 43(3):210-2. PubMed ID: 1675282
[TBL] [Abstract][Full Text] [Related]
15. Transcriptional regulation of mu opioid receptor gene by cAMP pathway.
Lee PW; Lee YM
Mol Pharmacol; 2003 Dec; 64(6):1410-8. PubMed ID: 14645671
[TBL] [Abstract][Full Text] [Related]
16. Reduced expression of a novel mu-opioid receptor (MOR) subtype MOR-1B in CXBK mice: implications of MOR-1B in the expression of MOR-mediated responses.
Narita M; Imai S; Ozaki S; Suzuki M; Narita M; Suzuki T
Eur J Neurosci; 2003 Dec; 18(12):3193-8. PubMed ID: 14686893
[TBL] [Abstract][Full Text] [Related]
17. Differences in delta opioid receptor antinociception, binding, and mRNA levels between BALB/c and CXBK mice.
Kest B; Beczkowska I; Franklin SO; Lee CE; Mogil JS; Inturrisi CE
Brain Res; 1998 Sep; 805(1-2):131-7. PubMed ID: 9733948
[TBL] [Abstract][Full Text] [Related]
18. Gene expression profiling in the striatum of inbred mouse strains with distinct opioid-related phenotypes.
Korostynski M; Kaminska-Chowaniec D; Piechota M; Przewlocki R
BMC Genomics; 2006 Jun; 7():146. PubMed ID: 16772024
[TBL] [Abstract][Full Text] [Related]
19. Differences in tolerance to anti-hyperalgesic effects between chronic treatment with morphine and fentanyl under a state of pain.
Imai S; Narita M; Hashimoto S; Nakamura A; Miyoshi K; Nozaki H; Hareyama N; Takagi T; Suzuki M; Narita M; Suzuki T
Nihon Shinkei Seishin Yakurigaku Zasshi; 2006 Nov; 26(5-6):183-92. PubMed ID: 17240843
[TBL] [Abstract][Full Text] [Related]
20. Guinea pig mu opioid receptor: brainstem expression in the morphine-exposed neonate.
Smith SA; Stupfel JT; Ilias NA; Olsen GD
Neurotoxicol Teratol; 2004; 26(1):121-9. PubMed ID: 15001221
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
